Immune Design Corp. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/61bab434-af54-4795-9924-7cfa403f79b3/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-57.0M | 2018-01-01 – 2018-12-31 | evidence 0001437786-19-000006 |
| FY 2017 | $-52.8M | 2017-01-01 – 2017-12-31 | evidence 0001437786-18-000013 |
| FY 2016 | $-54.2M | 2016-01-01 – 2016-12-31 | evidence 0001437786-17-000014 |
| FY 2015 | $-39.5M | 2015-01-01 – 2015-12-31 | evidence 0001437786-16-000031 |
| FY 2014 | $-29.9M | 2014-01-01 – 2014-12-31 | evidence 0001628280-15-002068 |
| FY 2013 | $-15.1M | 2013-01-01 – 2013-12-31 | evidence 0001628280-15-002068 |
| FY 2012 | $-10.9M | 2012-01-01 – 2012-12-31 | evidence 0001628280-15-002068 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).